156 related articles for article (PubMed ID: 15681579)
1. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002.
Ho PL; Shek RH; Chow KH; Duan RS; Mak GC; Lai EL; Yam WC; Tsang KW; Lai WM
J Antimicrob Chemother; 2005 Mar; 55(3):326-32. PubMed ID: 15681579
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
Ho PL; Ho AY; Chow KH; Wong RC; Duan RS; Ho WL; Mak GC; Tsang KW; Yam WC; Yuen KY
J Antimicrob Chemother; 2005 Jun; 55(6):840-5. PubMed ID: 15857942
[TBL] [Abstract][Full Text] [Related]
3. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
Chia JH; Chu C; Su LH; Chiu CH; Kuo AJ; Sun CF; Wu TL
J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
[TBL] [Abstract][Full Text] [Related]
4. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.
Schlesinger J; Navon-Venezia S; Chmelnitsky I; Hammer-Münz O; Leavitt A; Gold HS; Schwaber MJ; Carmeli Y
Antimicrob Agents Chemother; 2005 Mar; 49(3):1150-6. PubMed ID: 15728917
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens.
Park YJ; Yu JK; Lee S; Park JJ; Oh EJ
Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873
[TBL] [Abstract][Full Text] [Related]
7. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
Hoffmann H; Stürenburg E; Heesemann J; Roggenkamp A
Clin Microbiol Infect; 2006 Apr; 12(4):322-30. PubMed ID: 16524408
[TBL] [Abstract][Full Text] [Related]
9. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
[TBL] [Abstract][Full Text] [Related]
10. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
[TBL] [Abstract][Full Text] [Related]
11. Emergence of extended-spectrum β-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil.
Nogueira Kda S; Paganini MC; Conte A; Cogo LL; Taborda de Messias Reason I; da Silva MJ; Dalla-Costa LM
Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):87-92. PubMed ID: 23587705
[TBL] [Abstract][Full Text] [Related]
12. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
She D; Liu Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
[TBL] [Abstract][Full Text] [Related]
13. Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study.
De Champs C; Chanal C; Sirot D; Baraduc R; Romaszko JP; Bonnet R; Plaidy A; Boyer M; Carroy E; Gbadamassi MC; Laluque S; Oules O; Poupart MC; Villemain M; Sirot J
J Antimicrob Chemother; 2004 Sep; 54(3):634-9. PubMed ID: 15282240
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
Navon-Venezia S; Chmelnitsky I; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2008 Aug; 62(2):289-95. PubMed ID: 18487232
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G
Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641
[TBL] [Abstract][Full Text] [Related]
17. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
19. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
20. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
